Constitutive Intra-Articular Expression of Human IL-1β Following Gene Transfer to Rabbit Synovium Produces All Major Pathologies of Human Rheumatoid Arthritis

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3604-3612

  Ghivizzani, Steven C ^a   Kang, Richard ^a   Georgescu, Helga I ^a   Lechman, Eric R ^a   Jaffurs, Daniel ^a   Engle, J Michael ^a   Watkins, Simon C ^a   Tindal, Michael H ^b   Suchanek, Maureen K ^b   McKenzie, Lorraine R ^a   Evans, Christopher H ^a,c   Robbins, Paul D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Procter and Gamble USA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1;

ANIMAL; ARTICLE; ARTICULAR CARTILAGE; AUTOTRANSPLANTATION; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DISEASE MODEL; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; KNEE; METABOLISM; PATHOLOGY; RABBIT; RHEUMATOID ARTHRITIS; SYNOVIUM; TRANSPLANTATION;

ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CELL LINE; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-1; KNEE JOINT; RABBITS; SYNOVIAL MEMBRANE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0031253812     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arend, W. P., and J.-M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38:151.
2. Dingle, J. T., D. P. Thomas, B. King, and D. R. Bard. 1987. In vivo studies of articular tissue damage mediated by catabolin/interleukin-1. Ann. Rheum. Dis. 46:527.
3. Feige, U., A. Karbowski, C. Rordorf-Adam, and A. Pataki. 1989. Arthritis induced by continuous infusion of hr-interleukin-1α into the rabbit knee-joint. Int. J. Tissue React. 11:225.
4. Bandara, G., G. M. Mueller, J. Galea-Lauri, M. H. Tindal, H. I. Georgescu, M. K. Suchanek, G. L. Hung, J. C. Glorioso, P. D. Robbins, and C. H. Evans. 1993. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA 90:10764.
5. Hung, G. L., J. Galea-Lauri, G. M. Mueller, H. I. Georgescu, L. A. Larkin, M. Tindal, P. D. Robbins, and C. H. Evans. 1993. Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther. 1:64.
6. Dinarello, C. A 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314.
7. Pettipher, E. R., G. A. Higgs, and B. Henderson. 1986. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Prac. Natl. Acad. Sci. USA 83:8749.
8. Stimpson, S. A., F. G. Dalldorf, I. G. Otterness, and J. H. Schwab. 1988. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J. Immunol. 140:2964.
9. Postlethwaite, A. E., R. Raghow, G. P. Stricklin, H. Poppleton, J. M. Seger, and A. H. Kang. 1988. Modulation of fibroblast functions by interleukin 1: increased steady-slate accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1α and β. J. Cell. Biol. 106:311.
10. Arner, E. C., T. M. DiMeo, D. M. Ruhl, and M. A. Pratta. 1989. In vivo studies on the effects of human recombinant interleukin 1β on articular cartilage. Agents Actions 27:254.
11. Chandrasekhar, S., A. K. Harvey, P. S. Hrubey, and A. M. Bendele. 1990. Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin. Immunol. Immunopathol. 55:382.
12. Chandrasekhar, S., A. K. Harvey, and P. S. Hrubey. 1992. Intra-articular administration of interleukin-1 causes prolonged suppression of cartilage proteoglycan synthesis in rats. Matrix 11:1.
13. McDonnell, J., L. A. Hoerrner, M. W Lark, C. Harper, T. Dey, J. Lobner, B. Eiermann, D. Kazazis, I. I. Singer, and V. L. Moore. 1992. Recombinant human interleukin-1β-induced increase in levels of proteoglycans, stromelysin and leukocytes in rabbit synovial fluid. Arthritis Rheum. 53:799.
14. Wilder, R. 1993. Rheumatoid arthritis (A) epidemiology, pathology, and pathogenesis. In Primer on the Rheumatic Diseases. H. R. Schumacher, ed. Arthritis Foundation, Atlanta, GA, pp. 86-89.
15. Dranoff, G. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539.
16. Robbins, P. D., H. Tahara, G. M. Mueller, G. Hung, A. Bahnson, L. Zitvogel, J. Galea-Lauri, T. Ohashi, K. Patrene, S. Boggs, C. H. Evans, J. A. Barranger, and M. T. Lotze. 1993. Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis. Ann. NY Acad. Sci. 716:72.
17. Ghattas, I. R., J. R. Sanes, and J. E. Majors. 1991. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and embryos. Mol. Cell. Biol. 11:5848.
18. Tahara, H., L. Zitvogel, W. J. Storkus, H. J. Zeh, T. G. McKinney, R. D. Schreiber, V. Gubler, P. D. Robbins, and M. T. Lotze. 1994. Effective eradication of established murine tumors with interleukin-12 (IL-12) gene therapy. J. Immunol. 154:6466.
19. Zitvogel, L., H. Tahara, Q. Cai, W. J. Storkus, G. Mueller, S. F. Wolf, M. Gately, P. D. Robbins, and M. T. Lotze. 1994. Construction and characterization of retroviral vectors expressing biologically active human interleukin 12. Hum. Gene Ther. 5:1493.
20. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392.
21. Kang, R., P. D. Robbins, and C. H. Evans. 1997. Methods in gene transfer to synoviocytes. In Methods in Molecular Biology: Gene Therapy Protocols. P. D. Robbins, ed. Humana Press, Totowa, NJ, pp. 357-368.
22. Georgescu, H. I., D. Mendelow, and C. H. Evans. 1988. HIG-82: an established cell line from rabbit periarticular soft tissue which retains the "activatable" phenotype. In Vitro 24:1015.
23. Farndale, R. W., D. J. Buttle, and J. J. Barrett. 1986. Improved quantitation and discrimination of sulfated glycosaminoglycans by use of methylene blue. Biochim. Biophys. Acta 883:173.
24. Price, J., D. Turner, and C. Cepko. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84:156.
25. Witsch-Prehm, P., A. Karbowski, B. Ober, and H. Kresse. 1992. Influence of continuous infusion of interleukin-1α on the core protein and the core protein fragments of the small proteoglycan decorin in cartilage. J. Orthop. Res. 10:276.
26. Hopkins, S. J., M. Humphreys, and M. I. V. Jayson. 1988. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin. Exp. Immunol. 72:422.
27. Saxne, T., M. A. Palladino, D. Heinegard, N. Talal, and F. A. Wollheim. 1988. Detection of tumor necrosis factor a but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31:1041.
28. Brennan, F. M., D. Chantry, A. Jackson, R. Maini, and M. Feldmann. 1989. Inhibitory effects of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244.
29. Haworth, C., F. M. Brennan, D. Chantry, M. Turner, R. N. Maini, and M. Feldmann. 1991. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur. J. Immunol. 21:2575.
30. Maini, R. N., M. J. Elliott, F. M. Brennan, and M. Feldmann. 1995. Beneficial effects of tumour necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA). Clin. Exp. Immunol. 101:207.
31. Hirano, T., S. Akira, T. Taga. and T. Kishimoto. 1990. Biological and clinical aspects of interleukin-6. Immunol. Today 11:443.